{"organizations": [], "uuid": "0f84b653d02e346fc97058f40d8ff4271e7d515b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180202.html", "section_title": "Archive News &amp; Video for Friday, 02 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-medivir-completes-directed-issue-o/brief-medivir-completes-directed-issue-of-around-155-mln-sek-idUSFWN1PS0E3", "country": "US", "domain_rank": 408, "title": "BRIEF-Medivir completes directed issue of around 155 mln SEK", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-02T15:12:00.000+02:00", "replies_count": 0, "uuid": "0f84b653d02e346fc97058f40d8ff4271e7d515b"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-medivir-completes-directed-issue-o/brief-medivir-completes-directed-issue-of-around-155-mln-sek-idUSFWN1PS0E3", "ord_in_thread": 0, "title": "BRIEF-Medivir completes directed issue of around 155 mln SEK", "locations": [], "entities": {"persons": [{"name": "medivir", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "stockholm newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 2 (Reuters) - Medivir Ab:\n* MEDIVIR HAS COMPLETED A DIRECTED SHARE ISSUE OF APPROXIMATELY 155 MSEK\n* MEDIVIR SAYS ‍COMPANY INTENDS TO USE NET PROCEEDS FROM DIRECTED ISSUE TO MORE RAPIDLY ADVANCE DEVELOPMENT OF COMPANY‘S CLINICAL PORTFOLIO WHILE SIMULTANEOUSLY CONDUCTING OUT-LICENSING DISCUSSIONS FOR MIV-711, WITH AMBITION OF ENTERING INTO A PARTNER AGREEMENT DURING 2018​ Source text for Eikon: Further company coverage: (Reporting by Stockholm Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-02T15:12:00.000+02:00", "crawled": "2018-02-03T21:17:25.030+02:00", "highlightTitle": ""}